https://pubmed.ncbi.nlm.nih.gov/32627151/
https://www.ncbi.nlm.nih.gov/pubmed/32627151?dopt=Abstract
https://journals.viamedica.pl/ginekologia_polska/article/view/GP.2020.0057
https://journals.viamedica.pl/ginekologia_polska/article/view/65892
Circulating omentin-1 levels and inflammation in polycystic ovary syndrome.
Ginekol Pol. 2020;91(6):308-312
Authors: Franik G, Sadlocha M, Madej P, Owczarek A, Skrzypulec-Plinta V, Plinta R, Chudek J, Olszanecka-Glinianowicz M
Abstract
OBJECTIVES: The aim of the study was to analyze interrelation between plasma omentin-1 levels and nutritional status and inflammation in PCOS.
MATERIAL AND METHODS: A cross-sectional study involving 86 PCOS (47 obese) and 72 Non-PCOS women (41 obese) determined anthropometric parameters and body composition. Serum glucose, insulin and omentin-1, TNF-α, sTNFRs, IL-6 and sR-IL6 were measured in the fasting state.
RESULTS: Plasma omentin-1 levels were significantly lower in the PCOS than in the Non-PCOS group and both corresponding normal weight and obese subgroups. In three analyzed least-angle regression (LARS) models the lower plasma omentin- 1 levels was associated with PCOS occurrence, higher circulating TNF-α and lower IL-6 levels.
CONCLUSIONS: Suppressed omentin-1 levels in PCOS are characteristic for this disturbance and proinflammatory cytokines are factors modifying secretion of this adipokine.
PMID: 32627151 [PubMed – in process]
